Patient Home Monitoring Corp.
TSX VENTURE : PHM

June 18, 2015 09:00 ET

Patient Home Monitoring Corp. (PHM) Announces It Has Initiated Process to Graduate to TSX Senior Exchange

Announces Conference Call Thursday, June 25, 2015

LOS ANGELES, CALIFORNIA--(Marketwired - June 18, 2015) - Patient Home Monitoring Corp. ("PHM") (TSX VENTURE:PHM), a profitable acquisition-oriented company focused on rolling-up annuity-based healthcare service companies in the US and Canada, is pleased to announce that it has initiated the process for graduation from the Toronto Venture Stock Exchange to list on the Toronto Stock Exchange (the "TSX").

PHM also announced it will hold a conference call next week on Thursday, June 25th, 2015 at 1 p.m. EST to update investors on the financial impact of the recent acquisition and plans going forward.

Participants from PHM will be Michael Dalsin (Chairman), Roger Greene (Vice Chairman) and Edward Brann (M&A Banker).

The details of the call are:

Thursday, June 25th, 2015 at 1 p.m. EST
US & Canada Toll Free:
Dial In: (855) 886-8711
Meeting ID Number: 699 11 155

Financial professionals are invited to call in and ask questions. To pre-register as a qualified caller, please e-mail dwilson@myphm.com by 5 p.m. EST Wednesday, June 24th, 2015.

"After our recent acquisition, PHM has been attracting more and more interest from the US investment community," said Michael Dalsin, Chairman of Patient Home Monitoring. "We believe that a senior exchange listing will make a US listing much easier and quicker. I expect our listing on a US exchange will happen sooner than expected."

About PHM

The explosive growth in the number of elderly patients in the US healthcare market is creating pressure to provide more efficient delivery systems. Healthcare providers, such as hospitals, physicians and pharmacies, are seeking partners that can offer a range of products and services that improve outcomes, reduce hospital readmissions, and help control costs. PHM fills this need by delivering a growing number of specialized products and services to achieve these goals. PHM is a positive cash flow and profitable company that serves patients with heart disease and other chronic health conditions, this operation is a platform for acquisitions and organic growth. PHM is focused on a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. Because of the new and highly fragmented nature of the market, PHM is actively working to identify and evaluate profitable, annuity-based companies to acquire their patient databases and technical expertise at favorable prices. PHM's post acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services and making life easier for the patient. The expected result is growing EPS with each acquisition and growing revenue and profits from the cross selling efforts.

Forward-Looking Statements

Information in this news release that is not current or historical factual information may constitute forward-looking information within the meaning of securities laws. Implicit in this information, particularly in respect of the future outlook of PHM and anticipated events or results, are assumptions based on beliefs of PHM's senior management as well as information currently available to it. While these assumptions were considered reasonable by PHM at the time of preparation, they may prove to be incorrect. Readers are cautioned that actual results are subject to a number of risks and uncertainties, including the availability of funds and resources to pursue operations, decline of reimbursement rates, dependence on few payors, possible new drug discoveries, a novel business model, dependence on key suppliers, granting of permits and licenses in a highly regulated business, competition, low profit market segments as well as general economic, market and business conditions, and could differ materially from what is currently expected.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information